Page 3 - Best Acute lymphoblastic leukemia doctors: TOP 79 doctors

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Globally recognized leader in chronic lymphocytic leukemia (CLL) and lymphomas – Dr. Bosch pioneers new treatments and molecular research at Hospital Quiron Barcelona.

• Leads over 80 clinical trials, from phase 1 to phase 3
• Published 100+ studies in top journals like NEJM and Nature Medicine
• Heads Spanish CLL research group and clinical trials
• Post-doctoral fellowship at Columbia University's Institute of Cancer Genetics

Professor Zila Zuckerman specializes in hematology and transplantology at Rambam Medical Center.

• Expert in treating acute lymphoblastic leukemia
• Specializes in transplantology for blood disorders
• Professor with extensive academic and clinical experience

Head of Hematology at Hadassah Medical Center – Professor Ben-yehuda pioneered gene therapy and bone marrow transplants for acute lymphoblastic leukemia.

• Trained at Memorial Sloan-Kettering Cancer Center in New York
• First female Dean of Hadassah School of Medicine
• Specializes in molecular diagnostics and immunology
• Recipient of the Healing with the Heart Award for exceptional patient care

Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants at Hadassah Medical Center.

• 28 years of experience specializing in pediatric bone marrow transplants
• Focused on rare blood cancer diseases in children
• Known among patients as 'the one who transplants life'
• Leads a dedicated pediatric hematology unit

Dr. Ofer Spielberg is a specialized oncohematologist, focusing on blood cancers like leukemia.

• Practices at Assuta Medical Center
• Expertise in oncohematology, the field dedicated to blood cancers
• Provides targeted treatment for acute lymphoblastic leukemia

Specializes in acute leukemia and stem cell transplantation – Professor Omay brings 36 years of experience of hematology expertise from Turkey's top institutions.

• Head of Hematology Department at Emsey Hospital
• Trained in molecular hematology at Japan's Mie Medical School
• Published 65+ scientific articles on hematology treatments
• Performs both autologous and allogeneic stem cell transplants

Professor Dr. Birol Baytan specializes in childhood cancers at Emsey Hospital, leading international research and chemotherapy supervision.

• Expert in pediatric hematology-oncology with 34 years of experience of experience
• Published 15+ articles in international journals on childhood cancers
• Department head at Emsey Hospital since 2019
• Supervises entire chemotherapy courses with personalized follow-up

Associate Professor in Hematology with 50+ publications – Dr. Eren specializes in blood disorders at Biruni University Hospital.

• Completed Hematology subspecialty training at Istanbul Training and Research Hospital
• Member of European Society of Hematology and Turkish Hematology Association
• Recipient of Young Researcher Award at National Hematology Congress
• Fluent in English for international patient consultations

Dr. Apak specializes in pediatric hematology-oncology with over 26 years of experience of experience, focusing on acute lymphoblastic leukemia at Biruni University Hospital.

• Expert in bone marrow transplantation and CAR T-cell therapy
• Authored 75 international publications in pediatric oncology
• Head of Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa
• Member of Turkish Pediatric Society and Turkish Adolescent Association

Prof. Dogu specializes in hematologic cancers, with a focus on leukemia and lymphoma, at Liv Hospital Ulus – one of Turkey's leading medical centers.

• 36 years of experience of experience in hematology
• Board member of The Society of Hematological Education and Research
• Published 32 articles in international medical journals
• Trained at Ege and Pamukkale Universities
• Associate Professor at Istanbul Training and Research Hospital